BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19535446)

  • 1. Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells.
    Sherer NM; Swanson CM; Papaioannou S; Malim MH
    J Virol; 2009 Sep; 83(17):8525-35. PubMed ID: 19535446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Determinants Directing HIV-1 Gag Assembly to Virus-Containing Compartments in Primary Macrophages.
    Inlora J; Chukkapalli V; Bedi S; Ono A
    J Virol; 2016 Oct; 90(19):8509-19. PubMed ID: 27440886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
    Ono A; Orenstein JM; Freed EO
    J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RRE-dependent HIV-1 Env RNA effects on Gag protein expression, assembly and release.
    López CS; Sloan R; Cylinder I; Kozak SL; Kabat D; Barklis E
    Virology; 2014 Aug; 462-463():126-34. PubMed ID: 24971705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of viral assembly in murine cells by HIV-1 matrix.
    Hübner W; Chen BK
    Virology; 2006 Aug; 352(1):27-38. PubMed ID: 16750235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.
    Ramalingam D; Duclair S; Datta SA; Ellington A; Rein A; Prasad VR
    J Virol; 2011 Jan; 85(1):305-14. PubMed ID: 20980522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.
    Ristic N; Chin MP
    Retrovirology; 2010 Sep; 7():73. PubMed ID: 20825656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.
    Rye-McCurdy TD; Nadaraia-Hoke S; Gudleski-O'Regan N; Flanagan JM; Parent LJ; Musier-Forsyth K
    J Virol; 2014 Jul; 88(14):7852-61. PubMed ID: 24789780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.
    Jones CP; Datta SA; Rein A; Rouzina I; Musier-Forsyth K
    J Virol; 2011 Feb; 85(4):1594-603. PubMed ID: 21123373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Membrane Anchoring and Gag:Gag Multimerization on Viral RNA Are Critical Properties of HIV-1 Gag Required To Mediate Efficient Genome Packaging.
    Duchon A; Santos S; Chen J; Brown M; Nikolaitchik OA; Tai S; Chao JA; Freed EO; Pathak VK; Hu WS
    mBio; 2021 Dec; 12(6):e0325421. PubMed ID: 34872357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.
    Cockrell AS; van Praag H; Santistevan N; Ma H; Kafri T
    Retrovirology; 2011 Jun; 8():51. PubMed ID: 21702950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elements in HIV-1 Gag contributing to virus particle assembly.
    O'Carroll IP; Soheilian F; Kamata A; Nagashima K; Rein A
    Virus Res; 2013 Feb; 171(2):341-5. PubMed ID: 23099087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel nuclear export activity in HIV-1 matrix protein required for viral replication.
    Dupont S; Sharova N; DéHoratius C; Virbasius CM; Zhu X; Bukrinskaya AG; Stevenson M; Green MR
    Nature; 1999 Dec; 402(6762):681-5. PubMed ID: 10604476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles played by acidic lipids in HIV-1 Gag membrane binding.
    Olety B; Ono A
    Virus Res; 2014 Nov; 193():108-15. PubMed ID: 24998886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly.
    Ott DE; Coren LV; Shatzer T
    J Virol; 2009 Aug; 83(15):7718-27. PubMed ID: 19457986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrovirus-specific differences in matrix and nucleocapsid protein-nucleic acid interactions: implications for genomic RNA packaging.
    Sun M; Grigsby IF; Gorelick RJ; Mansky LM; Musier-Forsyth K
    J Virol; 2014 Jan; 88(2):1271-80. PubMed ID: 24227839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between MA-RNA Binding in Cells and Suppression of HIV-1 Gag Mislocalization to Intracellular Membranes.
    Thornhill D; Olety B; Ono A
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.